ORANGE, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced that the Centers for Medicare and Medicaid Services (CMS) recalculated the 2024 Star Rating of its H5296 Medicare Advantage (MA) HMO contract in North Carolina and Nevada, resulting in a 5-star out of a possible 5-star rating. Every year, CMS evaluates plans based on a 5-star rating, with 5 stars representing “excellent” performance.
“We’re pleased that CMS has revised the rating of our HMO contract in North Carolina and Nevada to achieve the highest possible score, recognizing excellent performance in delivering high-quality care at a lower cost,” said John Kao, founder and CEO, Alignment Health. “Our commitment to high-quality care extends to all our plans as more than 90% of Alignment members are enrolled in plans rated 4 stars or higher, meaning most of our members consistently receive a high-quality care experience.”
The improvement increases the contract’s overall star rating by 0.5 star, from 4.5 to 5 stars. According to CMS, the more stars a plan receives, the better the plan.
Alignment Health Plan, which entered North Carolina in 2021, earned 5 stars the first year it was eligible to be rated and was one of only two MA HMO plans in the state to achieve a 5-star rating in 2023.
For more information about Alignment Health Plan, visit www.alignmenthealthplan.com.
About Alignment Health
Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health offers more than 50 benefits-rich, value-driven Medicare Advantage plans that serve 53 counties across six states. The company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. Based in California, the company’s mission-focused team makes high-quality, low-cost care a reality for members every day. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit https://www.alignmenthealth.com/.
Investor Contact
Harrison Zhuo
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Contact
Priya Shah
mPR, Inc. for Alignment Health
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$19.39 |
| Daily Change: | 0.17 0.88 |
| Daily Volume: | 788,730 |
| Market Cap: | US$3.880B |
November 19, 2025 October 30, 2025 September 08, 2025 August 27, 2025 July 30, 2025 | |

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load